Mydecine Innovations Group is a next-generation biotechnology company that is no stranger to headlines. From their inception in 2020, they have made quite...
Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6 | WKN:A3CSSU) is pleased to announce that scientists at its wholly-owned subsidiary Awakened...
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada The post Field Trip facilitates beneficial...
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program The post Filament administers psilocybin...
The article Cathie Wood’s ARK Invest Releases Psychedelic Research Report was originally published on Microdose. We’ve been reporting on controversial...
Filament Health Corp (OTCQB: FLHLF | NEO: FH) (FSE: 7QS), a clinical‐stage natural psychedelic drug development company, and ATMA Journey Centers, a...
Amidst the ongoing biotech market slowdown, companies are trying various ways to stay afloat. Some are going public, and some are taking on debt. The newest...